skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

More than two-fifths of new drugs approved in the US last year were orphan drugs, and there are more than 4,500 drugs in active development for rare diseases. Effective orphan drug legislation and incentivization programs introduced gradually around the world since the 1980s mean rare diseases are no longer a rare sighting in the pharma industry pipeline, as this infographic illustrates.

 

 rare disease infographic

 

Find out more about Scrip here.

Read also

  • Scrip: industry news and insights, Medtech Insight: global m...

    Pharmaceutical News and Insights

    Understand what’s happening in the market right now and what it means for the future of your business with news and insight from our team of journalists and analysts.  Pharma Intelligence's News Sources are essential for anyone making commercial decisions in the pharmaceutical industry.

  • In Vivo: strategic insights for life sciences decision-maker...

    Pharma News and Healthcare Business Insights

    Pharma Intelligence offers a wealth of pharmaceutical industry news and strategic insight into the healthcare & biotechnology markets from around the world. Working in an interconnected global network, our 65 journalists and over 300 in-house analysts supply comprehensive analysis and reports.

  • Scrip: industry news and insights

    Idorsia’s Quviviq Needs To Rise And Shine After Slow Launch

    26 Jul 2022

    The company’s Quviviq launch has fallen short of early expectations, but Idorsia believes a patient approach will pay off for...

;

Next steps

Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: